Lab workup · Full case

Hypercalcaemia

NICE CKS

2.1–2.6Normal corrected calcium (mmol/L)

>2.6Mild/moderate hypercalcaemia — investigate

>3.5Severe hypercalcaemia — 999 / same-day hospital

90%Hypercalcaemia caused by primary HPT or malignancy

PTH ↑Elevated PTH = primary/tertiary HPT → endocrine referral

PTH ↓Suppressed PTH = malignancy / non-PTH cause → cancer screen

2 samplesTwo elevated corrected calcium samples required before acting on mild elevation

2 L/dayHydration target for all hypercalcaemia; first-line non-pharmacological measure

📋 Clinical Stem — Hypercalcaemia

A patient is found to have an elevated corrected serum calcium, either incidentally or following investigation of symptoms.

"Mrs Patricia Okafor is a 55-year-old accountant who presents after her routine blood test showed a corrected calcium of 2.78 mmol/L. She takes calcium carbonate 500 mg and vitamin D 800 IU daily for osteoporosis prevention. She reports fatigue, occasional constipation, and vague abdominal discomfort over the past 3 months. Her mother had breast cancer. She is worried the test result means she has cancer."

The hypercalcaemia consultation hinges on one pivotal question: is the PTH elevated (HPT) or suppressed (malignancy/other)? PTH is the test that determines the entire management pathway. Before referring for parathyroidectomy, CCCR must exclude FHH. In SCA, the cancer fear must be directly addressed while communicating appropriate diagnostic uncertainty.

Scenario A — Incidental mild hypercalcaemia (2.6–3.0) Confirm on repeat sample. Stop supplements. Check PTH. If PTH elevated: primary HPT → endocrine referral. If PTH suppressed: cancer screen urgently.

Scenario B — Severe hypercalcaemia (>3.5) or symptomatic Confusion, extreme fatigue, polyuria, severe nausea. Same-day hospital admission. IV saline rehydration. IV bisphosphonate (specialist). Treat underlying cause.

Scenario C — Primary hyperparathyroidism confirmed PTH elevated + calcium elevated. Stop supplements. 24-hour urine calcium (CCCR) to exclude FHH before parathyroidectomy referral. Surgery vs cinacalcet vs surveillance.

Scenario D — Malignancy-associated hypercalcaemia PTH suppressed. Solid tumour or myeloma. 2WW cancer referral urgently. IV bisphosphonate for hypercalcaemia management (hospital). Do not manage in primary care.

Scenario E — Drug-induced or supplement-related Calcium carbonate, vitamin D, thiazides, lithium. Stop the causative agent. Recheck calcium in 4–6 weeks. Most reversible cause.

Key variables Calcium level (mild vs severe); PTH result (HPT vs non-HPT); symptom burden; drug causes; cancer history; CCCR ratio (FHH vs primary HPT); renal function (tertiary HPT in CKD).

Steps:

Step 1

History Taking — Symptoms, Drug Causes, Cancer Screen, ICE

▲collapse

Hypercalcaemia history has three goals: assess symptom severity (determines urgency), screen for drug/supplement causes (most reversible), and identify clinical features that point to the underlying cause (HPT vs malignancy vs other). The "bones, groans, moans and stones" mnemonic covers the clinical syndrome: bone pain and fragility fractures, abdominal symptoms (nausea, constipation, peptic ulcer), neuropsychiatric symptoms (depression, confusion), and renal stones.

🎓 SCA opener

"I can see from your recent blood test that your calcium level has come back a little higher than normal — I want to explain what that means and make sure we get to the bottom of it together. First, can you tell me how you've been feeling over the past few months — any particular symptoms that have been troubling you?"

Reference the result. Normalise the finding ("a little higher") without either catastrophising or dismissing. Invite the patient to lead with symptoms before exploring the ICE (cancer fear will emerge naturally or should be proactively asked).

1A — Key questions

Question	Why it matters	Changes what?
🟢 OPEN — always start here"How have you been feeling — any symptoms that might fit with this result?"	Symptoms determine urgency: mild elevation with no symptoms = time for investigation; symptomatic (confusion, severe nausea, polyuria) = same-day admission. Also reveals the impact on daily life and opens the ICE conversation.	UrgencyPsychosocial
Fatigue, depression, cognitive change"How has your energy been? Any low mood, difficulty concentrating, or feeling confused?"	Neuropsychiatric symptoms (fatigue, depression, cognitive slowing, confusion) are common in hypercalcaemia and often the presenting complaint. They are frequently attributed to depression, menopause, or stress — hypercalcaemia is a commonly missed secondary cause of depression.	DDxUrgency
GI symptoms"Any nausea, vomiting, constipation, or abdominal pain?"	GI symptoms (nausea, constipation, abdominal pain) are characteristic of hypercalcaemia ("groans"). Peptic ulceration (calcium stimulates gastrin) can coexist. Constipation from hypercalcaemia is a common presenting complaint — often managed as functional constipation without the metabolic cause being identified.	DDx
Renal symptoms"Any kidney stones? Increased thirst or urination?"	Renal stones (calcium oxalate) and nephrocalcinosis are long-term complications of hypercalcaemia. Polyuria and polydipsia occur from nephrogenic diabetes insipidus (calcium impairs ADH action). Renal stones support a diagnosis of primary HPT (longstanding hypercalcaemia). Also guides urgency: stones + hypercalcaemia = treat HPT.	DDxReferral
Bone pain or fractures"Any bone pain — particularly in the hips, back, or long bones? Any recent fractures?"	Bone pain and fragility fractures ("bones") indicate osteoclast activation from PTH or PTHrP. Severe osteitis fibrosa cystica (rare) occurs in severe longstanding HPT. Bone metastases cause pain + hypercalcaemia and must be distinguished from HPT — both cause bone pain.	DDxUrgency
Drug history — calcium, vitamin D, thiazides, lithium"What medications and supplements are you taking — including any calcium tablets, vitamin D, water tablets, or medications for mood?"	Drug/supplement causes are the most immediately reversible: calcium carbonate + vitamin D supplements (this patient takes both), thiazide diuretics (reduce renal calcium excretion), lithium (stimulates PTH secretion). Stopping the causative agent and rechecking in 4–6 weeks often resolves the hypercalcaemia.	DDxManagement
Cancer history and weight loss"Have you ever been treated for cancer? Any unexplained weight loss or night sweats?"	Malignancy is the second most common cause of hypercalcaemia (after primary HPT). PTH-suppressed hypercalcaemia = malignancy until proven otherwise. Known cancer history + hypercalcaemia = urgent oncology review. Weight loss + hypercalcaemia + PTH suppressed = cancer screen urgently.	UrgencyDDx

1B — Red flags

🚨

Red Flags

Red flag	Why dangerous	Action
Calcium >3.5 mmol/L	Severe hypercalcaemia: cardiac arrhythmia (shortened QT interval), acute kidney injury, coma. Requires IV saline rehydration and IV bisphosphonate urgently.	Same-day hospital admission
Hypercalcaemia + confusion or reduced consciousness	Hypercalcaemic crisis — life-threatening. CNS toxicity from calcium. Needs urgent IV rehydration and electrolyte correction.	999 immediately
Hypercalcaemia + weight loss + night sweats + known or suspected cancer	Malignancy-associated hypercalcaemia — from PTHrP, bone metastases, or myeloma. Requires 2WW cancer referral and IV bisphosphonate in hospital.	Urgent 2WW cancer referral
Hypercalcaemia + severe bone pain + anaemia + renal failure + SPEP band	Multiple myeloma — specific cancer causing hypercalcaemia through osteoclast activation. Requires 2WW haematology.	2WW haematology

1C — ICE

💡 Ideas

"What did you make of the blood result when you saw it — had you heard anything about high calcium before?"

Many patients have no framework for interpreting a calcium result. Others have Googled "high calcium" and encountered cancer links immediately. Establishing the model enables appropriate calibrated explanation.

😟 Concerns

"I want to ask directly — is there something particular you've been worried this result might mean?"

Cancer fear is the dominant concern in hypercalcaemia. The patient's mother had breast cancer — this family history will be in her mind. The concern must be named and addressed directly: "I want to be honest that we need to investigate to find the cause — the most common cause is a small gland problem, but I do want to check thoroughly, and I'll give you results face to face."

🎯 Expectations

"What were you hoping would happen today — are you looking for answers, or is there something specific you wanted to discuss?"

Many patients want certainty ("Is it cancer or isn't it?") — which cannot be given at this stage without PTH result. Setting realistic expectations for the investigation timeline is clinically important and prevents a return call with the incorrect interpretation of a result.

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases

"I want to ask directly — is there something specific you've been worried this might mean? Sometimes a calcium result brings up concerns about cancer."

"The first step is to check a hormone called PTH — that single test will tell us whether this is a gland problem or whether we need to look further."

"In the meantime, I'd like you to stop the calcium supplements — they could be contributing to this result and stopping them is the most immediate thing we can do."

Deductions

Not asking about drug/supplement causes — calcium carbonate is in the stem and is the first thing to stop
Not addressing cancer fear directly — patient's mother had breast cancer; this must be named
Not explaining what PTH is and why it is the pivotal test

🔴 Red

Drug causes not asked. Cancer fear not explored. PTH not mentioned. Patient leaves without understanding what happens next.

🟠 Amber

PTH mentioned but not explained. Calcium supplements identified but not stopped. Cancer fear acknowledged but not specifically addressed.

🟢 Green

Calcium supplements stopped immediately. PTH explained as the pivotal test. Cancer fear named and addressed with appropriate calibrated uncertainty. Results review face-to-face agreed.

Step 2

Triage Engine

▲collapse

Triage is driven by: calcium level (>3.5 = emergency), symptom burden, and whether malignancy is suspected.

🔴 Emergency

Same-Day Hospital

Act now

Calcium >3.5 mmol/LCardiac arrhythmia risk; IV saline urgently; same-day admission
Hypercalcaemia + confusionHypercalcaemic crisis; 999
Malignancy + severe hypercalcaemiaIV bisphosphonate in hospital; 2WW cancer referral

🟠 Urgent (days)

Urgent Investigation / Referral

Days to 2 weeks

PTH suppressed + no drug cause + symptomaticCancer screen: FBC, CXR, CT, SPEP, PTHrP → 2WW if suspected malignancy
PTH elevated + calcium 2.6–3.5 (primary HPT confirmed)Endocrine referral; 24-hr urine calcium first (FHH exclusion)
Weight loss + bone pain + anaemia + hypercalcaemiaMyeloma screen + 2WW haematology

🟢 Routine

Primary Care Investigation

GP practice

Mild incidental hypercalcaemia (2.6–2.8) on supplementsStop supplements; recheck calcium in 4–6 weeks; check PTH
Awaiting PTH result — mild asymptomaticHydrate 2L/day; stop supplements; face-to-face results in 7–10 days
Known primary HPT under surveillanceAnnual calcium, eGFR, DXA; parathyroidectomy criteria review

🎓 SCA Checkpoint — Step 2Tasks

Key phrase

"Your calcium level is 2.78 — that's above normal but not at the level that needs emergency treatment today. What it does need is a specific blood test called PTH, which will tell us the cause. I'd like you to come back to discuss the result face-to-face."

Deductions

Not distinguishing mild from severe — both require different urgency
Communicating a significant calcium result by letter or online portal alone — face-to-face is the appropriate standard

Step 3

Do I Need This Examination?

▲collapse

Examination in hypercalcaemia looks for signs of the underlying cause and assesses severity of the clinical syndrome.

Examination	Why it matters	Finding that changes management	Changes?
Hydration / general assessment	Hypercalcaemia causes dehydration (polyuria, vomiting). Clinical dehydration (dry mucous membranes, reduced skin turgor, tachycardia, postural hypotension) indicates moderate-severe hypercalcaemia requiring same-day treatment.	Dehydrated + Ca >3.0 → same-day hospital. Well-hydrated mild → oral fluids and outpatient investigation.	YES — urgency
Lymphadenopathy	Generalised lymphadenopathy in a patient with hypercalcaemia suggests lymphoma or sarcoidosis — granulomatous disease causes 1,25-OH vitamin D overproduction. Cervical lymphadenopathy in the presence of a suppressed PTH + hypercalcaemia strongly suggests malignancy.	Lymphadenopathy → urgent cancer screen; 2WW if malignancy suspected	YES
Bone tenderness / abdominal examination	Bone tenderness (sternum, ribs, vertebrae) in hypercalcaemia = myeloma or metastatic bone disease. Abdominal tenderness may indicate peptic ulcer (calcium stimulates gastrin) or pancreatitis (hypercalcaemia is a recognised cause).	Diffuse bone tenderness → myeloma screen urgently. Acute abdomen with hypercalcaemia → pancreatitis or surgical emergency	YES
Blood pressure	Hypertension is common in primary HPT (calcium has vasoconstrictive effects). Useful baseline before treatment. Hypotension with hypercalcaemia → dehydration / adrenal crisis (Addison's disease is a rare cause).	Hypotension → assess for dehydration + adrenal insufficiency	Context

Step 4

Do I Need This Investigation?

▲collapse

PTH is the single most important investigation — it determines the entire management pathway. No treatment decision should be made without PTH.

Investigation	Why this is the pivotal test	Result that determines management
PTH (parathyroid hormone) — FIRST TEST	PTH is the pivotal investigation. Elevated PTH with elevated calcium = primary (or tertiary) hyperparathyroidism → endocrine referral. Suppressed PTH with elevated calcium = non-PTH cause (malignancy, sarcoidosis, vitamin D toxicity, hyperthyroidism) → cancer screen. No management decision is possible without this test.	PTH ↑ → primary HPT → endocrine; 24-hr urine Ca (CCCR) before surgery. PTH ↓ → non-PTH cause → cancer screen urgently. PTH normal (inappropriately) → tertiary HPT or FHH.
Corrected serum calcium (repeat)	Confirm on at least 2 samples before investigation cascade. Single result can be artefactual (haemoconcentration, prolonged tourniquet time, high albumin). Corrected calcium = measured calcium + 0.02 × (40 − albumin). Must be corrected — never act on uncorrected calcium alone.	Two confirmatory elevated results → proceed with full investigation. One elevated only → repeat before acting. Normal on repeat → artefact; reassure and stop supplements.
24-hour urine calcium (CCCR)	Critical before parathyroidectomy referral. Calcio-creatinine clearance ratio (CCCR) <0.01 = FHH (familial hypocalciuric hypercalcaemia) — a benign genetic condition where surgery FAILS. CCCR must be calculated before referral for parathyroidectomy; performing surgery on FHH is an avoidable harm.	CCCR <0.01 → FHH; do not refer for parathyroidectomy. CCCR >0.02 → primary HPT confirmed; refer to endocrine for surgical consideration.
Cancer screen (if PTH suppressed)	FBC, ESR, SPEP, CXR, CT chest/abdomen/pelvis, PTHrP. Malignancy is the second most common cause of hypercalcaemia. PTHrP (parathyroid hormone-related protein) is secreted by solid tumours (lung, breast, renal, squamous cell). Elevated PTHrP + suppressed PTH = humoral hypercalcaemia of malignancy.	Malignancy identified → 2WW cancer referral urgently; IV bisphosphonate in hospital. Normal cancer screen → consider sarcoidosis (ACE level, CXR), vitamin D toxicity, hyperthyroidism.
eGFR, ALP, vitamin D level	eGFR: hypercalcaemia causes nephrocalcinosis and CKD; eGFR also guides urgency. ALP elevated: suggests bone disease (metastases, Paget's) or liver metastases. Vitamin D level: vitamin D toxicity from supplements causes hypercalcaemia with suppressed PTH.	eGFR <60 → nephrocalcinosis; treat urgently. Elevated ALP → bone metastases or Paget's. Vitamin D >250 nmol/L → toxicity; stop supplements immediately.

🎓 SCA Checkpoint — Step 4Tasks

Key phrase

"The most important test I'm going to request today is called PTH — it's a parathyroid hormone test. This single test will tell us whether this is coming from a small gland in your neck, or whether we need to look for another cause. Everything else follows from that result."

Deductions

Not ordering PTH — proceeding without the pivotal test
Referring for parathyroidectomy without 24-hour urine calcium (CCCR) — may operate on FHH

Step 5

Reaching a Diagnosis — Explained in Plain Language

▲collapse

🗣 Explaining the Result in Plain Language

"Your calcium level is higher than normal — calcium is a mineral in the blood that is normally kept in a very tight range by a small gland in your neck called the parathyroid gland. When calcium is too high, it can cause fatigue, constipation, and the kind of general malaise you've been describing. The most common reason for this — accounting for about 90% of cases — is that one of the parathyroid glands becomes overactive and releases too much of a hormone that raises calcium. This is usually a benign condition called hyperparathyroidism. The other important cause we need to rule out is a cancer that can also raise calcium, which is why I'm not going to give you false reassurance today. The key test that will separate these two possibilities is called PTH — parathyroid hormone. Once we have that result, I'll call you in to discuss it face to face."

💬 Addressing cancer fear directly

"Does this mean I have cancer like my mother?"
"That's really important to address, and I want to be direct with you. I can't tell you for certain that it isn't, because we need the tests to find out. But I want to reassure you that the most common cause of this finding is a benign gland problem called hyperparathyroidism — not cancer. I'm taking this seriously enough to investigate it properly, and I'll give you the results in person, not by letter. If the parathyroid hormone comes back elevated, that's the benign gland. If it comes back low, that would tell us we need to look further — and we would do that urgently. I don't want to worry you unnecessarily, but I also don't want to dismiss your concern."

A — Most common (90%)

Primary hyperparathyroidism

PTH elevated + calcium elevated. Benign adenoma in 85%. Referral to endocrine; 24-hr urine Ca before surgery. Surgery vs cinacalcet vs surveillance depending on age/symptoms.

Drug/supplement-induced

Calcium carbonate, vitamin D, thiazides, lithium. Stop agent. Recheck in 4–6 weeks. Most reversible cause.

B — PTH suppressed: investigate

Malignancy (PTHrP-mediated)

PTH suppressed + PTHrP elevated. Solid tumour (lung, breast, renal, squamous cell). 2WW cancer referral. IV bisphosphonate for hypercalcaemia management.

Sarcoidosis / granulomatous disease

PTH suppressed + elevated ACE + bilateral hilar lymphadenopathy. Corticosteroids (prednisolone 20–40 mg/day) effective. Refer respiratory/rheumatology.

C — Emergency

Hypercalcaemic crisis (Ca >3.5)

IV saline rehydration 200–300 mL/hr. IV bisphosphonate (zoledronate) after rehydration. ITU if confused. Mortality without treatment.

Myeloma

PTH suppressed + anaemia + bone pain + SPEP monoclonal band. 2WW haematology urgently.

🎓 SCA Checkpoint — Step 5TasksRelating to Others

Key phrases

"The most common cause is a benign gland problem in the neck — not cancer. But I'm investigating properly rather than just assuming, because I want to be thorough for you."

"I'll give you the results face to face — not by letter or online. This is a result that deserves a proper conversation."

Deductions

False reassurance before PTH result ("It's definitely just a gland problem") — premature certainty before investigation
Not committing to face-to-face results discussion
Cancer fear not directly named and addressed

Step 6

If Referral Is Needed

▲collapse

Indication	Urgency	GP does before referral	Must NOT do
Ca >3.5 or hypercalcaemic crisis	Same-day hospital	IV access; take bloods (Ca, PTH, FBC, eGFR, ECG); call 999 or direct admission	Do not give oral calcium supplements; do not give thiazide diuretics
PTH elevated (primary HPT)	Routine endocrine	Stop calcium/vitamin D supplements; calculate CCCR from 24-hr urine calcium; DXA; eGFR; document symptom burden	Never refer for parathyroidectomy without CCCR — CCCR <0.01 = FHH; surgery fails and is harmful
PTH suppressed + cancer suspected	2WW cancer	FBC, CXR, CT, SPEP, PTHrP, ESR; 2WW referral to appropriate cancer pathway (oncology, haematology depending on suspected primary)	Do not manage hypercalcaemia alone without addressing cancer screen urgently
Primary HPT unsuitable for surgery (cinacalcet consideration)	Routine endocrine	Document reasons surgery unsuitable; calcium level trend; renal function; stop supplements	Do not initiate cinacalcet in primary care without specialist endocrine input

Step 7

Management — Expectation · Goals · Lifestyle · Drug Cards · Follow-Up · Safety-Netting

▲collapse

Primary care management of hypercalcaemia is largely investigative — the treatment is treating the cause, not the calcium level alone. In mild primary HPT: stop supplements, hydrate, and await endocrine review. In severe hypercalcaemia: IV saline is the first-line treatment (hospital). In malignancy: 2WW plus IV bisphosphonate (hospital). The GP's primary care role is: accurate diagnosis, appropriate triage, patient communication, and ensuring the right specialist receives the right information.

7A — Address cancer fear expectation

🤝

Validate → Explain → Negotiate

Validate

Cancer fear in the context of her mother's diagnosis is entirely understandable — say so explicitly.

"I understand completely why your mother's cancer comes to mind — this is exactly the kind of result that would make anyone worried."

Explain

The most common cause is benign (HPT). PTH will determine the pathway. Cannot give false certainty before results.

"The most common cause — accounting for about 9 in 10 cases — is a small benign gland problem. The test we're doing today will be definitive. I'll call you in to discuss the result in person."

Negotiate

Concrete next steps: stop supplements now, bloods today, face-to-face results in 7–10 days, hydration advice.

"Here's what happens next: stop the calcium tablet today, drink at least 2 litres of water a day, and I'll call you in 7–10 days to discuss the PTH result together."

7B — Treatment goals

Goals by aetiology

Calcium normalised to 2.1–2.6 mmol/L Drug/supplement cause identified and stopped PTH result obtained and correctly interpreted CCCR calculated before parathyroidectomy referral Cancer screen completed if PTH suppressed Hydration 2L/day maintained Results communicated face-to-face Anxiety about cancer fear addressed directly

Motivational language

"If the PTH comes back elevated, this is genuinely one of the most treatable causes of elevated calcium — often cured permanently with a straightforward operation."

"The fatigue and constipation you've been experiencing are very likely caused by the calcium level — and if we treat the cause, those symptoms should resolve."

7C — Immediate measures (all hypercalcaemia)

💧

Hydration

2L water/day minimum; IV saline if severe

Mechanism

Volume expansion promotes urinary calcium excretion via dilution and increased GFR. Dehydration worsens hypercalcaemia by concentrating calcium and reducing renal clearance. This is the first-line non-pharmacological intervention for any level of hypercalcaemia.

Practical

Target 2L water/day in mild cases. Avoid excessive coffee and alcohol (diuretic). For Ca >3.0 or symptomatic: IV normal saline in hospital (200–300 mL/hr with monitoring).

Adequate hydration reduces serum calcium by approximately 0.1–0.3 mmol/L in mild cases

🚪

Stop Calcium Supplements

Immediate — stop same day

Mechanism

Exogenous calcium supplementation in a patient with pre-existing hypercalcaemia from any cause will worsen the calcium level. Calcium carbonate (this patient's supplement) directly adds to calcium load and must be stopped immediately when hypercalcaemia is identified.

Practical

Stop calcium carbonate and vitamin D supplements today. Recheck calcium in 4–6 weeks — if calcium normalises, supplement-induced hypercalcaemia confirmed. If persists, proceed with PTH investigation.

Drug-induced hypercalcaemia resolves in most patients within 4–6 weeks of stopping the causative agent

✋

Avoid Exacerbating Factors

Thiazides, immobility, excessive sun/vitamin D

Mechanism

Thiazide diuretics reduce urinary calcium excretion — directly worsening hypercalcaemia. Prolonged immobility causes calcium efflux from bone. Excessive vitamin D (including high-dose supplements) causes 1,25-OH overproduction in granulomatous disease.

Practical

Review all medications for calcium-raising effects. Maintain mobility. Avoid high-dose vitamin D supplements until cause established.

Removing all exacerbating factors maximises effect of primary cause treatment

7D — Drug reference cards: hypercalcaemia agents

IV Normal Saline (0.9%)

Hospital management; 1–2 L bolus then 200–300 mL/hr

✓ Emergency first-line

Acute/severe1–6 L/day IV (hospital)

✓ Use when

Ca >3.0 or symptomatic (confusion, severe nausea, dehydration)

First-line treatment for moderate-severe hypercalcaemia

Before IV bisphosphonate (rehydrate first)

✗ Caution

Heart failure: risk of fluid overload; manage under specialist supervision

In SCA: IV saline is a hospital-initiated treatment. The GP's role is to recognise the need for same-day hospital admission, not to prescribe IV saline. Naming it as the first treatment in hospital demonstrates knowledge of the acute pathway.

Zoledronic Acid (IV Bisphosphonate)

Zometa 4 mg IV infusion; hospital-initiated

✓ Specialist-initiated

Specialist4 mg IV over 15 min (cancer/severe)

✓ Use when (hospital/specialist)

Severe hypercalcaemia (Ca >3.0) after rehydration with IV saline

Malignancy-associated hypercalcaemia — most effective agent

Inhibits osteoclast activity, reducing bone calcium efflux

✗ Avoid if

eGFR <35; dehydration (give IV saline first to protect kidneys)

⚠ Side effects

Acute phase reaction: flu-like symptoms 24–48 hrs; paracetamol covers this

Onset of effect: calcium reduces over 48–72 hrs; maximum effect at 4–7 days

In SCA: zoledronic acid is not primary care — it is hospital-initiated. Demonstrating knowledge that IV bisphosphonate follows rehydration (not concurrent) gains a Tasks mark. "The hospital would give IV saline first, then IV zoledronate after rehydration is established."

Cinacalcet (Calcimimetic)

Mimpara; 30 mg–90 mg twice daily; specialist-initiated

✓ Specialist HPT

Specialist HPT30–90 mg twice daily PO

✓ Use when

Primary HPT not suitable for surgery (age, comorbidities, patient preference)

Calcimimetic — increases sensitivity of parathyroid gland calcium-sensing receptor; reduces PTH secretion

Specialist-initiated only; does not cure HPT but controls calcium levels

✗ Avoid if

Hypocalcaemia; severe hepatic impairment

💬 Counselling

"This tablet works on the calcium-sensing system in the parathyroid gland to reduce the hormone that's been raising your calcium. It controls the calcium but doesn't remove the overactive gland — that requires an operation."

Prednisolone (Granulomatous Disease)

Prednisolone 20–40 mg/day; for sarcoidosis/lymphoma

✓ Sarcoidosis / granulomatous

Specific indication20–40 mg/day PO

✓ Use when

Sarcoidosis, lymphoma, or granulomatous disease causing hypercalcaemia via 1,25-OH vitamin D overproduction

PTH suppressed + ACE elevated + bilateral hilar lymphadenopathy on CXR

Corticosteroids block 1-alpha-hydroxylase in granulomatous tissue → reduces 1,25-OH vitamin D → reduces calcium

Not effective for HPT — cause-specific

In SCA: knowing that corticosteroids specifically treat sarcoidosis-related hypercalcaemia (and are ineffective for HPT) demonstrates specific mechanistic knowledge worth a Tasks mark. The mechanism: granulomas produce 1,25-OH vitamin D; steroids block this pathway.

Calcitonin (Short-Term Bridge)

Salmon calcitonin 4–8 IU/kg SC or IM; hospital

✓ Hospital bridge

Short-term hospital4–8 IU/kg SC/IM 6–12 hrly

✓ Use when

Rapid calcium reduction needed (onset 4–6 hrs) while waiting for bisphosphonate to work (48–72 hrs)

Bridging agent in crisis hypercalcaemia

✗ Limitation

Tachyphylaxis within 24–48 hrs — not for ongoing management; bridge only

In SCA: calcitonin as a bridging agent (rapid onset but short duration) demonstrates a high level of clinical knowledge. The key learning point: bisphosphonate takes 48–72 hrs for maximum effect; calcitonin provides rapid but transient calcium reduction in the interim.

Parathyroidectomy (Surgical)

Minimally invasive parathyroidectomy; sestamibi scan pre-op

✓ Definitive treatment

Definitive cureDay-case surgery; cure rate >95%

✓ Indicated when

Primary HPT confirmed (PTH elevated + CCCR >0.02 — FHH excluded)

Any age if symptomatic (renal stones, fragility fractures, nephrocalcinosis, significant symptoms)

Age <50 or calcium >2.85 or T-score <−2.5 or eGFR <60 — even if asymptomatic

✗ Must not refer without

CCCR from 24-hr urine calcium: CCCR <0.01 = FHH; surgery fails and is harmful in FHH

PTH confirmation: never refer for parathyroidectomy on calcium alone

In SCA: the CCCR / FHH exclusion step before parathyroidectomy referral is one of the most specific clinical knowledge points in hypercalcaemia. If asked "what would you do next if PTH comes back elevated?" — "I would refer to endocrine AND request a 24-hour urine calcium collection, because we need to exclude a condition called FHH before surgery is considered" gains a specific Tasks mark.

7E — Follow-up schedule

Today — Immediate actions

Stop calcium carbonate and vitamin D supplements today. Request PTH, repeat corrected calcium, eGFR, ALP, FBC. Advise 2L water/day. Book face-to-face results appointment in 7–10 days. Address cancer concern directly.

Immediate

7–10 days — PTH results review (face-to-face)

Discuss PTH result: if elevated → primary HPT pathway (CCCR, endocrine referral); if suppressed → cancer screen urgently (CT, CXR, SPEP, PTHrP). Never communicate this result by letter. Patient must have the conversation in person.

Face-to-face essential

4–6 weeks — Calcium recheck (if supplements were the cause)

If calcium normalised after stopping supplements: drug-induced confirmed. Continue monitoring. If still elevated: proceed with full PTH-driven investigation regardless of supplementation.

Recheck

Annual — Surveillance HPT (if not treating)

If primary HPT confirmed but surgery deferred (asymptomatic, age >50, mild elevation): annual calcium, eGFR, DXA, BP. Review criteria for intervention at each visit.

Annual

Post-parathyroidectomy — hungry bone syndrome monitoring

After parathyroidectomy: calcium may drop sharply ("hungry bone syndrome") — bone rapidly absorbs calcium. Check calcium daily for 2–3 days post-op, then weekly for 4 weeks. Calcium and vitamin D supplements may be needed post-operatively.

Post-surgical

7F — Safety-netting

⚠ Three scenario-specific safety-net phrases

TodayStop supplements; hydrate 2L/day; PTH bloods taken

7–10 daysFace-to-face PTH results discussion — non-negotiable

4–6 weeksCalcium recheck if supplement cause being tested; proceed with CCCR and endocrine referral if PTH elevated

🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills

Closing phrases

"The most important test is PTH — that will tell us whether this is a gland problem or something else. I'll call you in to discuss that result face-to-face within 10 days."

"Please stop the calcium tablet from today and drink at least 8 glasses of water a day."

"If you develop confusion, severe nausea, or feel very unwell before the appointment, please go to A&E and tell them about your calcium result."

"Is there anything else you'd like to ask before we finish?"

Deductions

Starting bisphosphonate in primary care without specialist input
PTH not ordered — proceeding without the pivotal test
Premature reassurance: "It's definitely just a gland problem" before PTH result
Raising cancer unprompted without calibrated language
Not stopping supplements immediately
Referring for parathyroidectomy without 24-hour urine calcium (CCCR)
Results communicated by letter or portal alone
Closing question absent

Tasks — full closing criteria

PTH requested as the pivotal test; explained to patient
Calcium supplements stopped immediately
Hydration 2L/day advised
Face-to-face results review committed to (7–10 days)
CCCR mentioned before any parathyroidectomy discussion
Emergency safety-net: confusion/severe symptoms = A&E
Supplement safety-net: do not restart before results

Relating to Others — full criteria

Cancer fear named and directly addressed with calibrated uncertainty
PTH explained as a plain-language concept
Family history (mother's breast cancer) acknowledged explicitly
Results approach committed to (face-to-face)
Understanding checked
Closing question asked

🔴 Red

PTH not ordered. Supplements not stopped. Cancer fear ignored. False certainty before results. No safety-net. Results by letter.

🟠 Amber

PTH ordered but not explained. Supplements stopped but reasoning not given. Cancer fear acknowledged but not addressed specifically. Face-to-face results not committed to.

🟢 Green

PTH explained as pivotal test. Supplements stopped immediately. Cancer fear addressed with calibrated uncertainty. Face-to-face results committed to. Emergency safety-net given. Closing question asked.

"The receptionist said you needed to see me about a blood test. I'm not sure what it's about — is something wrong?"

Who you are

Patricia Okafor, 55 years old, accountant. Presented after routine bloods showed corrected calcium 2.78 mmol/L. Takes calcium carbonate 500 mg OD and vitamin D 800 IU OD for osteoporosis prevention (prescribed by GP 2 years ago after low DXA). Reports fatigue, occasional constipation, and vague abdominal discomfort over 3 months (attributed to "getting older"). No polyuria, no renal stones, no bone pain. No personal cancer history. Mother had breast cancer — diagnosed at 58, died at 63. Otherwise well. No other medications.

Hidden agenda

Has not yet connected her symptoms to the calcium result but when told the calcium is elevated, she will immediately think of cancer — her mother had breast cancer and presented at a similar age. She will not raise this spontaneously. If the GP says "we need to do more tests" without explaining why or addressing cancer, she will leave extremely anxious. She needs three things to feel adequately supported: (1) the cancer fear proactively asked about and addressed; (2) honest acknowledgement that more investigation is needed without catastrophising; (3) face-to-face results promise.

If asked about symptoms

Fatigue: "Yes — I've been really tired, I thought it was just work stress"
Constipation: "Yes — I've been taking Fybogel but it's not really working"
Polydipsia or renal stones: "No, nothing like that"
Bone pain: "No specific pain"
Weight loss: "No — if anything I've put a little on"

If asked about supplements

"I take calcium tablets and vitamin D — the doctor put me on them 2 years ago for my bone scan"
If told to stop them: "Oh — okay, I'll stop them today"
If not told to stop: she will continue taking them (confounding the recheck result)

"Does this mean I might have cancer? My mother was about my age when she was diagnosed with breast cancer."

Resolution criteria: Patricia leaves feeling adequately supported if: (1) her cancer concern is proactively asked about (not just responded to if raised); (2) the GP is honest about needing investigation without catastrophising; (3) PTH is explained as the key test; (4) supplements are stopped; (5) face-to-face results review is committed to within 7–10 days; (6) emergency safety-net is given for worsening symptoms.

🏥

Clinic Quick Reference

Hypercalcaemia — Clinical Decision Framework

NICE CKS 2022 · BTA HPT Guidelines 2019

▼expand

🚦 1 — Triage by Calcium Level

🔴 Emergency / 2WW

Ca >3.5 → same-day hospital admission

Confusion + hypercalcaemia → 999

PTH suppressed + weight loss → 2WW cancer

Bone pain + anaemia + SPEP band → 2WW haematology

🟠 Urgent (7–10 days)

PTH result → face-to-face results review mandatory

PTH elevated → endocrine referral + CCCR

PTH suppressed → urgent cancer screen

🟢 Routine

Mild incidental + supplements → stop supplements; recheck 4–6 weeks

Known HPT surveillance: annual Ca/eGFR/DXA

📊 2 — Key Numbers and Decision Points

PTH first

Pivotal investigation — determines entire pathway

CCCR <0.01

FHH — never refer for parathyroidectomy in FHH

>3.5 mmol/L

Severe: same-day hospital; IV saline rehydration

90%

Hypercalcaemia caused by HPT or malignancy

2 samples

Two elevated corrected calcium readings before acting on mild elevation

2L/day

Hydration target in all hypercalcaemia

Stop supp

Stop calcium and vitamin D supplements immediately — most reversible cause

Face-to-face

Results must be communicated in person — not by letter/portal

PTH ↑

Primary HPT → endocrine; then 24-hr urine Ca (CCCR) before surgery

PTH ↓

Malignancy or other cause → urgent cancer screen (CT, SPEP, PTHrP)

⚠ 3 — Safety Netting and Follow-Up

Follow-up timeline

Today: Stop supplements; hydrate; PTH bloods

7–10 days: Face-to-face PTH results; pathway decision

4–6 wks: Calcium recheck if supplement cause being tested

Annual: HPT surveillance (Ca, eGFR, DXA, BP)

Post-op: Hungry bone syndrome — daily calcium monitoring

🎓

SCA Exam Quick Reference

SCA Consultation Blueprint

Tasks · Relating to Others · Global Skills · RAG guide

▼expand

🕐 12-Minute Flow

0–2 min

Reference Stem + Open

"Your calcium level has come back a little elevated. Tell me how you've been feeling — any particular symptoms over the past few months?"

GSRO

✗ Not referencing the calcium result context from stem

2–6 min

Symptoms + Drug Causes + ICE

"What supplements are you taking? Are you worried this result might mean something serious — sometimes people worry about cancer with these results."

TasksRO

✗ Not identifying calcium supplements · ✗ Not proactively asking about cancer fear

6–7 min

Examination

"I'd like to check for any lymph gland enlargement and assess your general state."

Tasks

✗ No examination when red flags possible

7–10 min

Explanation + PTH + Stop Supplements

"PTH — the parathyroid hormone test — is the key investigation. Stop the calcium supplement today. Most common cause is a benign gland problem, but I need the test before I can tell you more."

TasksRO

✗ False certainty before PTH · ✗ Not stopping supplements

10–12 min

Safety-Net + Face-to-Face + Close

"Results face-to-face in 7–10 days. If confusion or severe symptoms before then: A&E. Is there anything else?"

TasksRO

✗ Results by letter · ✗ No safety-net · ✗ No closing question

🔴🟠🟢 RAG Scoring

Tasks

🟢

PTH ordered and explained; supplements stopped; hydration advised; CCCR before parathyroidectomy; face-to-face results; emergency safety-net; 7–10 day follow-up

🟠

PTH ordered but not explained; supplements identified but not stopped; face-to-face not committed to; CCCR not mentioned

🔴

PTH not ordered; supplements not stopped; false certainty before results; cancer fear ignored; results by letter; no safety-net

Relating to Others

🟢

Cancer fear proactively asked; mother's cancer acknowledged; calibrated uncertainty; PTH explained in plain language; face-to-face committed to; closing question

🟠

Cancer fear addressed if raised but not proactively asked; PTH not explained; closing question absent

🔴

Cancer fear ignored; patient leaves extremely anxious; false certainty given; results by letter

💬 Key Phrases

Cancer fear

"I want to ask directly — are you worried this result might mean something serious? I know your mother had breast cancer and that this could be on your mind."

Calibrated uncertainty

"The most common cause is a benign gland problem — not cancer. But I'm investigating properly rather than just assuming, because I want to be thorough for you."

PTH explanation

"PTH is the hormone that controls your calcium. That single test will tell us whether this is a gland problem or whether we need to look further."

Supplements

"Please stop the calcium tablet from today — and don't restart it until we've had a chance to discuss the results."

Results commitment

"I'll call you in to discuss the results face-to-face within 10 days — not by letter. These results deserve a proper conversation."

🚫 9 Danger Zones

✗

Starting bisphosphonate in primary care without specialist input
→ Treat the cause; IV bisphosphonate is specialist-initiated in hospital

✗

PTH not ordered — proceeding without the pivotal test
→ PTH determines the entire pathway; no management decision possible without it

✗

Premature reassurance before PTH result
→ Never diagnose HPT before PTH; acknowledge calibrated uncertainty

✗

Cancer fear not proactively named
→ Ask directly; do not wait for patient to raise it

✗

Not stopping calcium and vitamin D supplements immediately
→ First actionable intervention; must happen same day

✗

Referring for parathyroidectomy without CCCR
→ CCCR <0.01 = FHH; surgery fails and harms in FHH

✗

Results communicated by letter or online portal alone
→ Face-to-face is the appropriate standard for a result of this significance

✗

Drug history not taken — missing the most reversible cause
→ Always ask about calcium, vitamin D, thiazides, and lithium

✗

Closing question not asked
→ Always end with "Is there anything else on your mind?"

💊 Management Quick-Pick

PTH elevated → primary HPT confirmed

→

Endocrine referral + 24-hr urine Ca (CCCR)

Surgery vs cinacalcet

PTH suppressed → malignancy suspected

→

2WW cancer referral + CT + PTHrP

Urgent oncology

Ca >3.5 or confusion

→

999 → IV saline → IV zoledronate

Hospital management

Sarcoidosis / granulomatous disease

→

Prednisolone 20–40 mg/day

Not for HPT

Supplement-induced (Ca+D3, thiazides)

→

Stop drug → recheck 4–6 weeks

Most reversible

HPT unsuitable for surgery

→

Cinacalcet (specialist-initiated)

Medical control only

✕ Always: hydration 2L/day · Stop supplements · Confirm on 2nd sample · Never refer for parathyroidectomy without CCCR to exclude FHH

Hypercalcaemia · GP Clinical Reasoning Framework v2 · NICE CKS Hypercalcaemia (2022) · BTA / BAETS HPT Guidelines (2019) · NICE NG12 (2WW cancer) · Endocrine Society Clinical Practice Guideline: Primary HPT 2022

v3: Dual tailored summaries · PTH-based differential diagnosis · FHH / CCCR distinction before parathyroidectomy · Emergency grading by calcium level · Cancer fear calibration in SCA communication

Teaching clinicians why each step matters — not just what to do · Always consult current BNF/SPC · Clinical judgement takes precedence · Results of this significance must always be communicated face-to-face

Hypercalcaemia

Red Flags

Same-Day Hospital

Urgent Investigation / Referral

Primary Care Investigation

Primary hyperparathyroidism

Drug/supplement-induced

Malignancy (PTHrP-mediated)

Sarcoidosis / granulomatous disease

Hypercalcaemic crisis (Ca >3.5)

Myeloma

Validate

Explain

Negotiate

Today — Immediate actions

7–10 days — PTH results review (face-to-face)

4–6 weeks — Calcium recheck (if supplements were the cause)

Annual — Surveillance HPT (if not treating)

Post-parathyroidectomy — hungry bone syndrome monitoring

⚠ Three scenario-specific safety-net phrases

🎭 Patient actor brief — click to practise

Who you are

Hidden agenda

If asked about symptoms

If asked about supplements